Need professional-grade analysis? Visit stockanalysis.com
$38.03B
31.87
17,284
3.58%
Price Chart
Risk-Adjusted Performance
Beijing Tongrentang Co Ltd (600085) Price Performance
Beijing Tongrentang Co Ltd (600085) trades on SHG in CNY. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at CNY27.73, down 0.75% from the previous close.
Over the past year, 600085 has traded between a low of CNY27.57 and a high of CNY38.14. The stock has lost 25.0% over this period. It is currently 27.3% below its 52-week high.
Beijing Tongrentang Co Ltd has a market capitalization of $38.03B, with a price-to-earnings ratio of 31.87 and a dividend yield of 3.58%.
About Beijing Tongrentang Co Ltd
Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverages applications. The company was founded in 1997 and is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tong Ren Tang Group Co. Ltd.
Compare Beijing Tongrentang Co Ltd
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Exchange
- SHG
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $17.26B
- EBITDA
- $2.27B
- Profit Margin
- 6.89%
- EPS (TTM)
- 0.87
- Book Value
- 9.96
Technical Indicators
- 52 Week High
- CN¥38.36
- 52 Week Low
- CN¥27.50
- 50 Day MA
- CN¥29.61
- 200 Day MA
- CN¥32.98
- Beta
- 0.26
Valuation
- Trailing P/E
- 31.87
- Forward P/E
- 28.17
- Price/Sales
- 2.20
- Price/Book
- 2.81
- Enterprise Value
- $30.93B